SCHEMBL3843396

SCHEMBL3843396

O=C(O)c1cccc(-c2ccccc2)c1CO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HNF4A P41235 1/20 0.61
FABP3 P05413 1/20 0.51
FABP4 P15090 1/20 0.51
FABP5 Q01469 1/20 0.51
BCAT2 O15382 1/20 0.50
ALDH1A1 P00352 3/20 0.48
ALOX15 P16050 1/20 0.48
FOLH1 Q04609 3/20 0.47
CDC25B P30305 1/20 0.47
ATM Q13315 1/20 0.47
MYC P01106 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PTPN1 P18031 2/20 0.45
CHRNB2 P17787 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10984209 0.85 HNF4A (0.58) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL8368463 0.85 HNF4A (0.58) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL10676967 0.85 HNF4A (0.49) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL8415183 0.85 HNF4A (0.58) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL8477925 0.83 ALDH1A1 (0.55) HNF4AALDH1A1ALOX15FOLH1MAPT
SCHEMBL7407371 0.81 HNF4A (0.73) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL6278249 0.81 HNF4A (0.53) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL29017085 0.81 SCN1A (0.47) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL27319579 0.80 HNF4A (0.56) HNF4AFABP3FABP4FABP5BCAT2
SCHEMBL36146 0.80 HNF4A (0.66) HNF4AFABP3FABP4FABP5BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906684-B2 Antioxidants MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-03-15 US disclosed
US-20090246158-A1 ANTIOXIDANTS MERCK PATENT GESELLSCHAFT (DE) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090246158-A1 ANTIOXIDANTS LPO, GPX1, GPX4 HNF4A 3956/4885FABP3 884/4885FABP4 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.